| Issue Date | Title | Author(s) |
| 2023-08-04 | [18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial. | Koh, E-S; Gan, HK; Senko, C; Francis, RJ; Ebert, M; Lee, ST; Lau, E; Khasraw, M; Nowak, AK; Bailey, DL; Moffat, BA; Fitt, G; Hicks, RJ; Coffey, R; Verhaak, R; Walsh, KM; Barnes, EH; De Abreu Lourenco, R; Rosenthal, M; Adda, L; Foroudi, F; Lasocki, A; Moore, A; Thomas, PA; Roach, P; Back, M; Leonard, R; Scott, AM |
| 2018-11 | Bayesian approach to determining penetrance of pathogenic SDH variants. | Benn, DE; Zhu, Y; Andrews, KA; Wilding, M; Duncan, EL; Dwight, T; Tothill, RW; Burgess, J; Crook, A; Gill, AJ; Hicks, RJ; Kim, E; Luxford, C; Marfan, H; Richardson, AL; Robinson, B; Schlosberg, A; Susman, R; Tacon, L; Trainer, A; Tucker, K; Maher, ER; Field, M; Clifton-Bligh, RJ |
| 2016-03 | Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma. | Flynn, A; Dwight, T; Harris, J; Benn, D; Zhou, L; Hogg, A; Catchpoole, D; James, P; Duncan, EL; Trainer, A; Gill, AJ; Clifton-Bligh, R; Hicks, RJ; Tothill, RW |
| 2018-11-01 | A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol | Hofman, MS; Murphy, DG; Williams, SG; Nzenza, T; Herschtal, A; De Abreu Lourenco, R; Bailey, DL; Budd, R; Hicks, RJ; Francis, RJ; Lawrentschuk, N |
| 2019-01-15 | Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer’s Disease | Cardoso, BR; Roberts, BR; Malpas, CB; Vivash, L; Genc, S; Saling, MM; Desmond, P; Steward, C; Hicks, RJ; Callahan, J; Brodtmann, A; Collins, S; Macfarlane, S; Corcoran, NM; Hovens, CM; Velakoulis, D; O’Brien, TJ; Hare, DJ; Bush, AI |
